Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers
NCT00483353 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2008-06-17
Summary
The current study will investigate nasal inflammatory markers obtained by filter paper collection techniques, in subjects with allergic rhinitis, determining the most appropriate time points and handling conditions, prior to running a larger study with subjects with allergic rhinitis.
Conditions
- Seasonal Allergic Rhinitis
Interventions
- PROCEDURE
-
Intra-nasal allergen challenge with Phleum pratense.
- PROCEDURE
-
Collection of nasal effluent using filter paper.
- PROCEDURE
-
Measurement of nasal congestion using acoustic rhinometry.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Nasal Allergen Challenge in Rhinitic Subjects
NCT01286129 ·Status: COMPLETED ·Phase: NA
-
PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS
NCT01586468 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat Nasal Allergen Challenge
NCT00290368 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
NCT00513487 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions
NCT00297843 ·Status: COMPLETED
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
NCT01393340 ·Status: COMPLETED ·Phase: PHASE2
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact
NCT05042830 ·Status: RECRUITING ·Phase: NA
-
Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis
NCT00443495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
NCT04544774 ·Status: RECRUITING
-
Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense
NCT01489033 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE
NCT00755066 ·Status: COMPLETED ·Phase: NA
-
An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
NCT01439815 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
NCT01185080 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis
NCT00730756 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
NCT01085526 ·Status: COMPLETED ·Phase: NA
-
Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis
NCT01275456 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis
NCT03887026 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis
NCT04976023 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)
NCT00673062 ·Status: COMPLETED ·Phase: PHASE2